SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-006554
Filing Date
2021-02-01
Accepted
2021-02-01 17:53:16
Documents
1
Period of Report
2021-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7600
  Complete submission text file 0001209191-21-006554.txt   9173
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 310 UTAH AVE, STE. 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE, STE. 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
Shabbir Anik (Reporting) CIK: 0001751728 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 21578058